This collection of research highlights advancements in kidney transplant immunosuppression. Focus areas include personalized strategies, management of donor-specific antibodies (DSA), and novel immunosuppressive agents…
stage organ failure. However, the long-term success of transplantation relies heavily on effective immunosuppression to prevent rejection. Traditional monitoring methods, such as biopsies and serum creatinine levels…
This review consolidates recent research on immunosuppression strategies for solid organ transplantation, aiming to enhance graft longevity. It highlights personalized approaches, the role of the microbiome and…
preventing graft rejection and improving long-term outcomes. The discussion encompasses the development of personalized immunosuppression regimens, immune tolerance induction, and the exploration of novel…
DCMi is an optimal heart failure medical regimen. Moreover, EMB is the basis for personalized immunosuppressive or antiviral treatment. In virus-positive DCMi Interferon-ß treatment is a well-tolerated ... effective and…
minimizing adverse effects. The report also addresses the growing importance of personalized medicine in tailoring immunosuppressive regimens to individual patient profiles. Furthermore, the document examines…
sampling simplify collection and enable decentralized testing, while pharmacogenomics allows for personalized dosing. TDM is vital for immunosuppressants, antimicrobials, and psychotropic medications, with point-of-care…
improved patient survival and graft longevity. Key areas of progress include optimized immunosuppression, organ preservation, and personalized medicine approaches utilizing biomarkers. Studies examine predictive…
novel agents like belatacept, which selectively inhibits T-cell activation, allowed for a personalized immunosuppression regimen. Furthermore, advanced monitoring techniques, including regular biomarker assessments and…
have improved patient outcomes. Key innovations include minimally invasive surgical approaches, the development of personalized immunosuppressive regimens to reduce rejection, and the use of advanced tissue engineering…
with an increased risk of infection and malignancy. This study highlights the need for personalized immunosuppressive strategies to optimize transplant outcomes while minimizing risks
disease, malignancy, medication adher ence, bone health, and psychosocial adjustment. Advancements in monitoring and personalized immunosuppression are ongoing. The impact of the microbiome on transplant outcomes is an…
rejection and drug toxicity. This overview highlights the shift towards non-invasive biomarkers and personalized immunosuppression, addressing challenges in differentiating rejection from drug-induced injury. Research…
role of precision medicine in enhancing compatibility and minimizing the risk of graft rejection. Immunosuppression remains a cornerstone in organ transplantation, and the third section reviews current protocols while…
that persist. Advancements include the rise of living donor kidney transplants, the development of personalized immunosuppressive regimens, innovative cross-match techniques, and the utilization of ex vivo perfusion to…
transplantation encounters persistent challenges. Immunological barriers, including graft rejection and the delicate balance between immunosuppression and infection susceptibility, remain formidable obstacles. The…
years, transplant surgery has witnessed significant advancements, driven by innovations in surgical techniques, immunosuppressive therapies, and organ preservation methods. This review explores recent developments in…
surgical techniques, such as single-lung and double-lung transplantation, alongside improvements in immunosuppressive therapies, have markedly enhanced patient outcomes and survival rates. However, the field continues…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.